 |
市场调查报告书
商品编码
1197854
骨科指间植入物市场——增长、趋势、COVID-19 影响和预测 (2023-2028)Orthopedic Digit Implants Market - Growth, Trends, and Forecasts (2023 - 2028) |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
在 2022 年至 2027 年的预测期内，骨科指间植入物市场预计将以 7% 的复合年增长率增长。
COVID-19 疫情对市场产生了重大影响。 联邦基金估计，COVID-19 将使 2020 年 5 月的首次就诊次数减少 60%。 预计这会削弱通常在门诊进行的骨科治疗的需要。 由于世界各国政府施加的社会动盪，医院和医疗服务严重减少，COVID-19 的爆发正在影响市场。 COVID-19 流行病也影响了全球经济，对世界各地医院中非 COVID-19 患者的标准医院护理实践产生了重大影响。 由于许多医院和诊所因设施关闭而关闭，短期内对数字骨植入物的需求将会减少。 根据英国外科杂誌发表的一项研究，2020 年 5 月，由于 COVID-19 导致主要医院服务中断 12 週或本应推迟，到 2020 年全球约有 2840 万次择期手术被取消。 根据国际组织 2020 年 5 月的一项研究，由于 COVID-19 流行病，印度有超过 580,000 例组织手术被取消或推迟。 这些不存在的服务的推迟减少了对数字骨植入物的需求。 然而，在 COVID-19 流行之后，随着召回服务的处理，对这种数字输入的需求将会增加。
不断增长的全球老年人口和不断上升的关节炎是数字人工授精市场的主要支柱。 此外，对微创技术的认识不断提高以及 3D 打印技术的出现彻底改变了骨科技术的使用。 预计这将对预测期内的市场增长产生积极影响。 根据文章《骨关节炎：根据 2021 年 2 月发表的“你需要知道的”》，到 2050 年，60 岁以上的人将占世界人口的 20% 以上，这是一个变态。这意味着生殖器关节炎患者人数将达到1.3亿。 关节炎患病率的上升和关节炎症状负担的增加预计将推动市场增长。
同样，根据联合国经济和社会事务部发布的《2020年人口老龄化亮点》报告，到2050年，全球将有15亿人超过65岁。 随着全球人口老龄化，患有骨质疏鬆症的人数可能会增加。 随着年龄的增长，我们的骨骼变得脆弱，更容易骨折。 因此，上述所有统计数据都表明世界人口正在快速增长，这将推动未来的市场增长。
此外，向市场推出新产品也将促进所研究市场的增长。 例如，2021 年 8 月，骨科植入物公司推出了一种名为 DRPx 系统的腕部骨折电镀技术，该技术具有增强的人体工程学设计，以满足骨科医生的手术偏好。
然而，有限的医疗保险引入和严格的监管政策预计将阻碍预测期内的市场增长。
骨科指间植入物的市场趋势
预计在预测期内，跖骨关节植入部分将占很大份额
由于关节炎的增加和全球风险的增加，预计跖骨合成植物将占据很大的市场份额。 治疗损伤最常见的手术之一是跖趾关节 (MTP) 植入的第一步。 在这项手术中，一个小型的两件式植入物覆盖了 MTP 关节中受损或缺失的关节软骨，大脚趾的球与脚相遇。 这种植入物可以恢復关节的活动能力，并允许关节之间相对平稳地移动。 该手术通常用于治疗大而僵硬的脚趾。
根据世界卫生组织 (WHO) 于 2021 年 6 月更新的数据，估计每年有 135 万人死于道路交通事故。 每年大约有 20 至 5000 万人在道路交通事故中受伤或致残。 这些新兴市场的发展预计将在预测期内对市场增长做出重大贡献。
此外，该细分市场新产品的推出有望在研究期间进一步推动市场增长。 例如，2021 年 2 月，Accufix Surgical 获得了美国食品和药物管理局 (FDA) 的批准，可以部署 AccuJoint 计划，这是一种在不降低坚固或脆弱骨骼的情况下恢復 MTP 功能和运动的新方法。我得到了 这是一种失重装置，足部外科医生可以为患者选择关节维护而不是关节整合。
此外，产品技术的进步和全球骨质疏鬆症负担的加重预计将对整个市场的增长产生积极影响。
预计在预测期内北美将显着增长
预计北美地区在预测期内将出现显着的市场增长。 这种增长的背后是骨质疏鬆症的高患病率、老年人口的增加以及不干扰治疗的外科手术的普及。 此外，更多市场参与者的出现和新产品的推出正在推动该地区的市场增长。
预计不断增长的老年人口将推动这一细分市场的增长。 例如，加拿大统计局2021年9月的数据显示，老年人口逐年增加。 它还报告说，2020 年 65 岁及以上人口占近 6,845,502 人，到 2021 年达到 7,081,792 人。 预计易患骨折和其他慢性病的人口老龄化将推动市场增长。
此外，该地区骨科数字化的引入有望进一步推动市场增长。 例如，2020 年 12 月，Ensemble Orthopedics Inc. 获得了美国食品和药物管理局的 510(k) 批准，可以安装 Ensemble CMC。 Ensemble CMC 旨在通过微创小手术治疗前腕踝关节 (CMC) 骨关节炎患者。
因此，由于上述原因，预计学习市场将在预测期内增长。
骨科指间植入物市场竞争者分析
骨科指间植入物市场相对分散，只有几家主要市场参与者。 市场参与者正专注于地域扩张、新产品发布和新产品开发。 主要市场参与者包括强生公司（DePuy Synthes）、施乐辉、史赛克公司、Integra LifeSciences、Accumed LLC 等。
其他好处
- Excel 格式的市场预测 (ME) 表
- 三个月的分析师支持
内容
第1章介绍
- 研究假设和市场定义
- 调查范围
第2章研究方法论
第 3 章执行摘要
第4章市场动态
- 市场概览
- 市场驱动因素
- 老龄化人口的增加和骨科疾病患病率的增加
- 对微创手术和先进产品的偏好不断上升
- 市场製约因素
- 严格的监管程序
- 术后感染和种植体适应性低
- 波特的五力分析
- 新进入者的威胁
- 买方/消费者议价能力
- 供应商的议价能力
- 替代品的威胁
- 竞争公司之间的敌对关係
第 5 章市场细分（基于价值的市场规模 - 百万美元）
- 按产品类型
- 跗管植入物
- 腕骨植入物
- 脚趾髓内植入物
- 舟骨植入物
- 新月骨植入物
- 按材料
- 热解碳
- 钛
- 镍钛诺
- 其他材料
- 最终用户
- 医院
- 骨科诊所
- 按地区
- 北美
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 意大利
- 西班牙
- 其他欧洲地区
- 亚太地区
- 中国
- 日本
- 印度
- 澳大利亚
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会
- 南非
- 其他中东地区
- 南美洲
- 巴西
- 阿根廷
- 其他南美洲
- 北美
第6章竞争格局
- 公司简介
- Smith & Nephew
- Johnson & Johnson
- Stryker Corporation
- Arthrex GmbH
- Vilex In Tennessee Inc.
- Merete GmbH
- Acumed LLC
- Teijin Limited
- Arthrosurface
- Advin Health Care
- Bond Well Ortho Products
- Zimmer Biomet
第7章 市场机会与今后动向
The orthopedic digit implants market is expected to register a CAGR of 7% over the forecast period, 2022-2027.
The COVID-19 epidemic has had a profound effect on the market. According to the Commonwealth Fund, it is estimated that there will be a 60% reduction in the initial outpatient visits in May 2020 due to COVID-19. This was expected to hurt the need for orthopedic sessions as is usually done in outpatient departments. The outbreak of COVID-19 has had an impact on the market, as hospital and health care services have been severely curtailed due to social unrest taken by governments around the world. In addition, the COVID-19 epidemic has affected the global economy and has shown a significant impact on the performance of standard hospital care for non-COVID-19 patients in hospitals around the world. As many hospitals and clinics remain closed due to the closure of facilities, the need for digital bone implants decreases in the short term. According to a study published in the British Journal of Surgery, in May 2020, based on 12 weeks of major hospital services disruption due to COVID-19, approximately 28.4 million elective surgeries worldwide will be canceled or postponed by 2020. More than 580,000 organized surgery in India was canceled or delayed due to the COVID-19 epidemic, according to a study by the international organization in May 2020. With the postponement of these non-existent services, the need for a digital bone implant has fallen. However, after the COVID-19 epidemic, the collected services will be handled, which increases the need for this digital input.
The increasing geriatric population worldwide and the rise of arthritis are the mainstays of the digital artificial insemination market. In addition, growing awareness about less intrusive technology and the advent of 3D printing technology has revolutionized the use of orthopedic technology. This is expected to have a positive impact on market growth in the forecast period. According to the article "Osteoarthritis: What You Need to Know" published in February 2021, people over the age of 60 will account for more than 20% of the world's population by 2050 which means the number of osteoarthritis sufferers will reach 130 million. The growing prevalence of arthritis and the increasing burden of arthritis conditions are expected to boost market growth.
Similarly, according to a report by the United Nations Department of Economics and Social Affairs, 2020 Highlights on Population Ageing, by 2050, globally, 1.5 billion people are living aged 65 years or over. With the growing number of elderly people worldwide, there may be an increase in the number of people suffering from osteoporosis. As a person grows older, his bones become weaker, which makes him more prone to fractures. Thus, all of the above statistics indicate that the world's population is growing rapidly, encouraging future market growth.
Additionally, the launch of new products in the market will also boost the studied market growth. For instance, in August 2021, the Orthopedic Implant Company launched wrist fracture plating technology, called the DRPx System with an enhanced ergonomic design to meet the technique preferences of orthopedic surgeons.
However, the introduction of limited medical insurance and strict regulatory policies are expected to hamper market growth over the forecast period.
Orthopedic Digit Implants Market Trends
The Meta Tarsal Joint Implants Segment is Expected to Hold a Significant Share Over the Forecast Period
Metatarsal integrated plants are expected to have a significant market share due to the increase in arthritis and the growing number of risks worldwide. One of the most common procedures for treating injuries is the first step in the metatarsal-phalangeal joint (MTP) transplant procedure. This procedure involves a small, two-piece implant to cover the damaged or missing articular cartilage in the MTP joint, where the base of the big toe meets the foot. The implant can restore mobility to the joints and allow them to move smoothly against one another. This procedure is often used to treat large hard toes.
According to the World Health Organization update in June 2021, an estimated 1.35 million people die as a result of road accidents each year. In addition, some 20 to 50 million people are injured or disabled each year as a result of road accidents. These developments are expected to make a significant contribution to market growth in the forecast period.
In addition, the introduction of new products in the segment is expected to further market growth during the study period. For example, in February 2021, Accufix Surgical received approval from the United States Food and Drug Administration (FDA) to roll out its Accu-Joint program, a new method of fully restoring MTP function and movement that does not degrade solid or weak bone. This is a weightless plant that allows surgeon foot surgeons to opt for joint maintenance over the joint integration of their patients.
In addition, advances in product technology and the increasing burden of osteoporosis worldwide are expected to have a positive impact on overall market growth.
North America Projected to Grow at Significant Rate Over the Forecasted Period
The North American region is expected to have significant market growth during the forecast period. Growth is due to the high prevalence of osteoporosis, an increase in the number of elderly people, and the increasing popularity of surgical procedures that do not interfere with treatment. In addition, the presence of more market players and the introduction of new products encourages market growth in the region.
The growing elderly population is expected to drive the growth of the market segment. For Instance, Statistics Canada. September 2021 data, the geriatric population is growing year on year. It also reported that in 2020, the population aged 65 years or over accounts for nearly 6,845,502 and it reached 7,081,792 in 2021. Such an increasing geriatric population which is more prone to fractures and other chronic diseases is expected to drive the growth of the market.
In addition, the introduction of digital orthopedic digitalization in the region is expected to further boost market growth. For example, in December 2020, Ensemble Orthopedics Inc. received 510 (k) approval from the United States Food and Drug Administration for its inclusion of the Ensemble CMC. Ensemble CMC is designed to treat patients with osteoarthritis of the anterior segment of the carpometacarpal joint (CMC) using a minimally invasive, simple surgical procedure.
Therefore, as a result of the above, the market learned is expected to grow during the forecast period.
Orthopedic Digit Implants Market Competitor Analysis
The Orthopedic Digit Implants market is moderately fragmented, with a few major market players. Market players are focusing on geographic expansions, new product launches, and the development of new products. The key market players include Johnson & Johnson (DePuy Synthes), Smith & Nephew, Stryker Corporation, Integra Lifesciences, and Acumed LLC.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Increasing Geriatric Population and Rising Prevalence of Orthopedic Diseases
- 4.2.2 Increasing Preference of Minimally Invasive Surgeries and Advanced Products
- 4.3 Market Restraints
- 4.3.1 Stringent Regulatory Procedures
- 4.3.2 Post Surgery Infections and low Adaptation of Implants
- 4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD Million)
- 5.1 By Product Type
- 5.1.1 Meta Tarsal Joint Implants
- 5.1.2 Meta Carpal Joint Implants
- 5.1.3 Toe Intramedullary Digit Implants
- 5.1.4 Scophoid Bone Digit Implants
- 5.1.5 Hemiphalangeal Digit Implants
- 5.2 By Material
- 5.2.1 Pyrocarbon
- 5.2.2 Titanium
- 5.2.3 Nitinol
- 5.2.4 Other Materials
- 5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Speciality Orthopedic Clinics
- 5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
- 5.4.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 Smith & Nephew
- 6.1.2 Johnson & Johnson
- 6.1.3 Stryker Corporation
- 6.1.4 Arthrex GmbH
- 6.1.5 Vilex In Tennessee Inc.
- 6.1.6 Merete GmbH
- 6.1.7 Acumed LLC
- 6.1.8 Teijin Limited
- 6.1.9 Arthrosurface
- 6.1.10 Advin Health Care
- 6.1.11 Bond Well Ortho Products
- 6.1.12 Zimmer Biomet
